Dopamine dysfunction in stimulant use disorders: mechanistic comparisons and implications for treatment
- PMID: 34117366
- PMCID: PMC8664889
- DOI: 10.1038/s41380-021-01180-4
Dopamine dysfunction in stimulant use disorders: mechanistic comparisons and implications for treatment
Abstract
Dopamine system deficiencies and associated behavioral phenotypes may be a critical barrier to success in treating stimulant use disorders. Similarities in dopamine dysfunction between cocaine and methamphetamine use disorder but also key differences may impact treatment efficacy and outcome. This review will first compare the epidemiology of cocaine and methamphetamine use disorder. A detailed account of the pharmacokinetic and pharmacodynamic properties associated with each drug will then be discussed, with an emphasis on effects on the dopamine system and associated signaling pathways. Lastly, treatment results from pharmacological clinical trials will be summarized along with a more comprehensive review of the involvement of the trace amine-associated receptor on dopamine signaling dysfunction among stimulants and its potential as a therapeutic target.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.
Conflict of interest statement
Conflict of Interest
The authors declare no conflicts of interest.
Figures
References
-
- World Drug Report 2020. (United Nations publication, Sales No. E.20.XI.6).
-
- Koob GF. Circuits, drugs, and drug addiction. Adv Pharmacol 1998; 42: 978–982. - PubMed
-
- Proebstl L, Kamp F, Manz K, Krause D, Adorjan K, Pogarell O et al. Effects of stimulant drug use on the dopaminergic system: A systematic review and meta-analysis of in vivo neuroimaging studies. Eur Psychiatry 2019; 59: 15–24. - PubMed
-
- Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI et al. Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 2001; 60(6): 1181–1188. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
